Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil.

Cancer genetics - 1 Jan 2000

Schayek Hagit, De Marco Luiz, Starinsky-Elbaz Sigal, Rossette Mariana, Laitman Yael, Bastos-Rodrigues Luciana, da Silva Filho Agnaldo Lopes, Friedman Eitan

Abstract excerpt

In Brazil, several recurring mutations in BRCA1 and BRCA2 and a TP53 mutation (R337H) have been reported in high risk breast cancer cases. We hypothesized that these recurring mutations may also be detected in the general population and ovarian cancer cases in the state of Minas Gerais. To test this notion, participants were recruited from the outpatient and the Gynecological clinic in the UFMG Medical Center in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Brazil

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genes, p53

Share to Germ-Line Mutation

Share to Neoplasm Recurrence, Local

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 26656232
DOI: 10.1016/j.cancergen.2015.11.003

Genes

BRCA2
BRCA1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil.PMID 26656232Read ↗

Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System.Semantic proximity Read ↗

Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.Semantic proximity Read ↗

Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil.Semantic proximity Read ↗

Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil.Semantic proximity Read ↗

High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.Semantic proximity Read ↗

A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population.Semantic proximity Read ↗

BRCA1 5382insC founder mutation has not a significative recurrent presence in Northeastern Romanian cancer patients.Semantic proximity Read ↗

Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.Semantic proximity Read ↗

TP53 mutations in breast cancer tumors of patients from Rio de Janeiro, Brazil: association with risk factors and tumor characteristics.Semantic proximity Read ↗

A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.Semantic proximity Read ↗

Analysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples.Semantic proximity Read ↗

Recurrent BRCA1 and BRCA2 Mutations in Mexican Women with Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.